Clinical trial
Open Label, Single-Arm Study of the Safety and Tolerability of a Leucine Enriched Essential Amino Acid Powder as an Add-on to a Classic Ketogenic Diet in Refractory Epilepsy
NCT06387186 is registered in ClinicalTrials.gov with Elizabeth Anne Thiele as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open Label, Single-Arm Study of the Safety and Tolerability of a Leucine Enriched Essential Amino Acid Powder as an Add-on to a Classic Ketogenic Diet in Refractory Epilepsy
- Lead sponsor
- Elizabeth Anne Thiele
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 10, 2024
- Completion date
- February 18, 2026
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
drug resistant epilepsy, refractory epilepsy